Back
Recursion Pharmaceuticals Stock Predictions
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
60
RXRX
Recursion Pharmaceuticals
Last Price:
7.27
Seasonality Move:
10.07%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.Recursion Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 15.5% based on the past 3 years of stock performance.
- Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Recursion Pharmaceuticals Stock Undervalued?
The current Recursion Pharmaceuticals [RXRX] share price is $7.31. The Score for RXRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal. - RXRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 15.5% based on the past 3 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Buy
60
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals overpriced?
- Recursion Pharmaceuticals has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
15.74
52-Week Low:
5.89
Prediction Charts
Market Cap:
2.1B
Price in USD:
7.31
Volume:
6.52M
Beta:
0.81
Technical Analysis
SMA50:
6.63
SMA100:
7.07
SMA200:
8.44
52-Wk Change:
25.39%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?
Yes, Recursion Pharmaceuticals is a publicly traded company. -
What is the Recursion Pharmaceuticals stock quote today?
The Recursion Pharmaceuticals stock price is 7.31 USD today. -
How to buy Recursion Pharmaceuticals stock online?
You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-25 | 6.42 | 6.48 | 6.61 | 6.28 |
| Oct-28 | 6.58 | 6.87 | 6.95 | 6.56 |
| Oct-29 | 6.85 | 6.74 | 6.85 | 6.65 |
| Oct-30 | 6.62 | 6.68 | 6.90 | 6.60 |
| Oct-31 | 6.65 | 6.33 | 6.69 | 6.32 |
| Nov-1 | 6.36 | 6.40 | 6.58 | 6.34 |
| Nov-4 | 6.40 | 6.62 | 6.69 | 6.22 |
| Nov-5 | 6.59 | 6.82 | 6.83 | 6.47 |
| Nov-6 | 6.95 | 6.97 | 7.05 | 6.77 |
| Nov-7 | 6.92 | 6.93 | 7.09 | 6.68 |
| Nov-8 | 6.86 | 7.10 | 7.21 | 6.81 |
| Nov-11 | 7.50 | 7.84 | 8.49 | 7.23 |
| Nov-12 | 7.52 | 7.58 | 8.05 | 7.43 |
| Nov-13 | 7.80 | 7.31 | 8.04 | 7.31 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.19 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.